Intermedical Pharma
Tracked across 1 events · 6 articles · First seen Sep 21, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
NuWays AG initiated coverage of Gallmetzer HealthCare SpA with a BUY recommendation and a 12-month target price of EUR 4.40 per share, based on a DCF valuation. Analyst Sarah Hellemann described Gallmetzer HealthCare as a…
Impact: Intermedical Pharma is highlighted as the unit that lets Gallmetzer HealthCare SpA enter the local anesthetics market through AIFA-approved marketing authorizations. NuWays sees it becoming a growth and margin engine, with dossier recognition in additional European countries as a catalyst.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Intermedical Pharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard